Ibruxen Ibrutinib 140 mg

DESCRIPTION

Ibruxen is a prescription drug used to treat patients with Mantle Cell Lymphoma (MCL), Chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL), Chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) with 17p deletion, Waldenstrom macroglobulinemia, Marginal zone lymphoma and Chronic craft versus hot disease. To buy Ibruxen or to know its price contact 3S Corporation.

Manufacturer : Everest Pharmaceuticals Ltd.

ADDITIONAL INFORMATION

Strengths available140 mg

Form : Capsules

Dosage : Recommended dosage for Mantle Cell Lymphoma (MCL) and Marginal zone lymphoma- 560 mg (four 140mg capsules) orally once daily until disease progression or unacceptable toxicity.

Recommended dosage for Chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) and Waldenstrom macroglobulinemia- 420 mg (three 140mmg capsules) orally once daily until disease progression or unacceptable toxicity.

Recommended dosage for Chronic craft versus hot disease– 420 mg (three 140mg capsules) orally once daily until progression, recurrence of an underlying malignancy, or  unacceptable toxicity.

Storage : Store between  20°C  and 25°C

SIDE EFFECTS

Common side effects are diarrhea, thrombocytopenia, anemia, neutropenia, fatigue, musculoskeletal pain, upper respiratory tract infection, peripheral edema, nausea, dyspnea, bruising, rash, constipation, vomiting, decreased appetite and abdominal pain. 

PACK SIZE

Bottle of 120 capsules

Reviews

There are no reviews yet.

Be the first to review “Ibruxen Ibrutinib 140 mg”

Your email address will not be published. Required fields are marked *